Hemodynamic, molecular, and histological characterization of a toxic liver fibrosis regression model
Philipp Königshofer(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Ksenia Brusilovskaya(Austrian Academy of Sciences), Stefan Günther Kauschke, Benedikt Simbrunner(Austrian Academy of Sciences), Hubert Scharnagl(Medical University of Graz), Benedikt Hofer(Austrian Academy of Sciences), Michael Trauner(Medical University of Vienna), Tatjana Stojaković, Philipp Schwabl(Austrian Academy of Sciences), Larissa Pfisterer(Boehringer Ingelheim (Germany))
Cited by 0
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399